<?xml version="1.0" encoding="UTF-8"?>
<ref id="B32-pharmaceutics-13-00230">
 <label>32.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Mazzotta</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Cebrero-Cangueiro</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Frattaruolo</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Vega-Holm</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Carretero-Ledesma</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Sánchez-Céspedes</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Cappello</surname>
    <given-names>A.R.</given-names>
   </name>
   <name>
    <surname>Aiello</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Pachón</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Vega-Pérez</surname>
    <given-names>J.M.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Exploration of piperazine-derived thioureas as antibacterial and anti-inflammatory agents. In vitro evaluation against clinical isolates of colistin-resistant Acinetobacter baumannii</article-title>
  <source>Bioorg. Med. Chem. Lett.</source>
  <year>2020</year>
  <volume>30</volume>
  <fpage>127411</fpage>
  <pub-id pub-id-type="doi">10.1016/j.bmcl.2020.127411</pub-id>
  <pub-id pub-id-type="pmid">32717617</pub-id>
 </element-citation>
</ref>
